In:
International Journal of Research and Review, Galore Knowledge Publication Pvt. Ltd., Vol. 10, No. 7 ( 2023-7-19), p. 538-548
Kurzfassung:
People with Diabetes, particularly poorly controlled blood sugar levels, are at an increased risk of severe illness if they contract COVID-19. Diabetes has weakened the immune system, with more difficult for the body to fight infections. Studies have suggested a potential link between lipid abnormalities and COVID-19 severity. High levels of cholesterol and triglycerides, a component of the lipid profile, have been associated with increased inflammation and impaired immune response. This factor may contribute to a more severe course of COVID-19. Our study aims to investigate the Impact of COVID-19 on Lipid profiles in Diabetic Retinopathy of rural populations. Our study reported the potential direct and indirect effects of COVID-19 on the development and progression of DR, including the impact of Lipid Profile and glycemic Control due to altered healthcare access, changes in lifestyle, potential viral involvement, and vaccinations. By examining existing literature, analyzing patient data, and conducting surveys, this study provides valuable insights into the intersection between COVID-19 and DR. The specific relationship between diabetic Retinopathy, lipids, and COVID-19 is not well-established, and limited research is available on this topic. However, the results of this study contributed to information about the relationship between COVID-19, Lipids, and Diabetic Retinopathy, offering a foundation for future research and guiding clinical practice to improve patient outcomes.
Conclusion: In this study, we concluded that Dyslipidemia and Hyperglycemia increase the risk of progressing on Diabetic Retinopathy, but due to the breakthrough of covid-19, there was no significantly changed observed in the lipid profile and glycemic control pattern of individuals with diabetic Retinopathy. However, the number of cases increased dramatically toward the progression of Diabetes to Diabetic Retinopathy with significantly reduced age of diabetic individuals and Duration of Diabetes compared to before the breakthrough of COVID-19. Keywords: COVID-19 pandemic, glycemic control, Diabetic Retinopathy, vaccination, World Health Organization, severe acute respiratory syndrome coronavirus 2, Diabetic Eye Disease
Materialart:
Online-Ressource
ISSN:
2349-9788
,
2454-2237
DOI:
10.52403/ijrr.20230766
Sprache:
Englisch
Verlag:
Galore Knowledge Publication Pvt. Ltd.
Publikationsdatum:
2023
